FDA in a study published this week found that a number of the active ingredients found in popular sunscreens are absorbed into the bloodstream at levels higher than the agency recommends, prompting FDA to request further research on the safety of sunscreens.

The Trump administration last week told existing association health plans that they can continue operating, even though a federal court recently struck down parts of a federal rule that expanded the plans.

CMS on Thursday finalized a rule that intends to stop states from diverting Medicaid payments to third parties, with certain exceptions.

FDA on Thursday said it will not at this time ban the use of breast implants linked with hundreds of cases of a rare cancer, though the agency said it is considering requiring stricter warnings for breast implants.

A law in New Hampshire aims to help nurses with substance use disorders recover and keep their licenses by encouraging them to self-report their conditions.

The United States' total prescription drug costs are not expected to decrease if CMS finalizes a rule designed to prohibit drugmakers from paying rebates to pharmacy benefit managers, according to a Congressional Budget Office report released Thursday.

Tennessee's Legislature on Thursday approved a bill that directs state officials to ask the federal government to distribute the state's federal Medicaid funding in the form of a block grant, and in exchange give the state additional flexibility over how it administers its Medicaid program.

HHS on Thursday released a final rule intended to enforce protections for health care professionals who have moral or religious objections to certain medical care, including abortion care and assisted death.

Sen. Michael Bennet (D-Colo.), who last month introduced a so-called "Medicare X" proposal that would implement a public option health plan in the United States, on Thursday became the latest candidate to announce he is seeking the 2020 Democratic nomination for president.

FDA will require certain prescription sleep aids, including Ambien, Sonata, and Lunesta, to carry black-box warnings that display the drugs' risks, following reports that some patients who have taken the medications have experienced side effects that led to injury or death.